Keating Investment Counselors Inc Bristol Myers Squibb CO Transaction History

Keating Investment Counselors Inc

  • $244 Million
  • Q3 2024

A detailed history of Keating Investment Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keating Investment Counselors Inc holds 8,757 shares of BMY stock, worth $505,804. This represents 0.19% of its overall portfolio holdings.

Number of Shares
8,757
Previous 10,357 15.45%
Holding current value
$505,804
Previous $430,000 5.35%
% of portfolio
0.19%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$39.66 - $51.75 $63,455 - $82,800
-1,600 Reduced 15.45%
8,757 $453,000
Q2 2024

Aug 06, 2024
SELL
$40.25 - $52.99 $50,513 - $66,502
-1,255 Reduced 10.81%
10,357 $430,000
Q1 2024

May 07, 2024
SELL
$47.98 - $54.4 $404,231 - $458,320
-8,425 Reduced 42.05%
11,612 $629,000
Q4 2023

Feb 07, 2024
SELL
$48.48 - $57.85 $4,848 - $5,785
-100 Reduced 0.5%
20,037 $1.03 Million
Q2 2023

Aug 02, 2023
SELL
$63.71 - $70.74 $82,823 - $91,962
-1,300 Reduced 6.06%
20,137 $1.29 Million
Q1 2023

May 04, 2023
BUY
$65.71 - $74.53 $6,570 - $7,453
100 Added 0.47%
21,437 $1.49 Million
Q4 2022

Feb 08, 2023
BUY
$68.48 - $81.09 $116,416 - $137,853
1,700 Added 8.66%
21,337 $1.53 Million
Q3 2022

Nov 03, 2022
SELL
$0.13 - $76.84 $6 - $3,842
-50 Reduced 0.25%
19,637 $1.4 Million
Q2 2022

Aug 03, 2022
SELL
$72.62 - $79.98 $10,893 - $11,997
-150 Reduced 0.76%
19,687 $1.52 Million
Q1 2022

Apr 28, 2022
SELL
$61.48 - $73.72 $6,148 - $7,372
-100 Reduced 0.5%
19,837 $1.45 Million
Q3 2021

Oct 27, 2021
SELL
$59.17 - $69.31 $5,917 - $6,931
-100 Reduced 0.5%
19,937 $1.18 Million
Q1 2021

Apr 26, 2021
SELL
$59.34 - $66.74 $117,196 - $131,811
-1,975 Reduced 8.97%
20,037 $1.27 Million
Q3 2020

Oct 23, 2020
SELL
$57.43 - $63.64 $11,486 - $12,728
-200 Reduced 0.9%
22,012 $1.33 Million
Q4 2019

Jan 28, 2020
SELL
$49.21 - $64.19 $2,952 - $3,851
-60 Reduced 0.27%
22,212 $1.43 Million
Q3 2019

Oct 28, 2019
SELL
$42.77 - $50.71 $87,678 - $103,955
-2,050 Reduced 8.43%
22,272 $1.13 Million
Q1 2019

Apr 22, 2019
SELL
$45.12 - $53.8 $27,072 - $32,280
-600 Reduced 2.41%
24,322 $1.16 Million
Q3 2018

Oct 30, 2018
SELL
$55.19 - $62.25 $71,747 - $80,925
-1,300 Reduced 4.96%
24,922 $1.55 Million
Q2 2018

Aug 01, 2018
SELL
$50.53 - $62.98 $15,159 - $18,894
-300 Reduced 1.13%
26,222 $1.45 Million
Q1 2018

May 11, 2018
SELL
$59.92 - $68.98 $201,331 - $231,772
-3,360 Reduced 11.24%
26,522 $1.68 Million
Q3 2017

Nov 09, 2017
SELL
$55.23 - $63.74 $11,046 - $12,748
-200 Reduced 0.66%
29,882 $1.91 Million
Q2 2017

Aug 10, 2017
BUY
N/A
30,082
30,082 $1.68 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Keating Investment Counselors Inc Portfolio

Follow Keating Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keating Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Keating Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email